NCT06804382

Brief Summary

In this study, 50 pediatricians will participate in academic detailing, an evidence-based, 1-on-1 outreach education technique intended to promote clinician behavior change through brief, highly interactive, and individualized dialogues with trained educators, or "detailers". The goals of this study are to learn about whether this is a practical and acceptable technique, and whether it changes how pediatricians prescribe pre-exposure prophylaxis (PrEP) to adolescents and young adults (AYA) and how patients take it.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
36mo left

Started Apr 2027

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 22, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 3, 2025

Completed
2.2 years until next milestone

Study Start

First participant enrolled

April 1, 2027

Expected
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2030

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2030

Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

3 years

First QC Date

January 22, 2025

Last Update Submit

January 23, 2026

Conditions

Keywords

PrEPSTIAYAadolescenthiv preventionacademic detailing

Outcome Measures

Primary Outcomes (4)

  • Feasibility

    Feasibility will be assessed using survey question from other academic detailing campaigns and assessed on a 5-point Likert scale. Questions will be: "the key messages are feasible to implement in my practice" (1= not at all through 5= extremely)

    From enrollment to end of study interview at 4 months

  • Feasibility

    Feasibility of academic detailing based on number of enrolled providers who complete both academic detailing visits

    From enrollment to end of second academic detailing session at 1 month

  • Acceptability

    Acceptability of academic detailing as measured by provider satisfaction with the academic detailing visit. This will be assessed via the Prescriber Satisfaction with Academic Detailing questionnaire (PSAD). Answers are on a 5 point Likert scale (1=not at all through 5=extremely).

    From enrollment to end of second academic detailing visit at 1 month.

  • Acceptability

    Acceptability of academic detailing based on completion of academic detailing sessions

    From enrollment to end of second academic detailing session at 1 month

Secondary Outcomes (4)

  • Impact of academic detailing on PrEP knowledge and prescribing

    From enrollment to end of study interview at 4 months

  • Change in PrEP Prescriptions

    From 6 months prior to enrollment to 6 months after intervention

  • HIV Testing

    From 6 months prior to enrollment to 6 months after academic detailing intervention

  • Fidelity to intervention

    From enrollment to end of second academic detailing visit at 1 month.

Study Arms (1)

pediatricians

EXPERIMENTAL
Behavioral: Academic detailing

Interventions

Academic detailing is an evidence-based, 1-on-1 outreach education technique intended to promote clinician behavior change. Information gained during earlier focus groups will be used to develop study-specific materials.

pediatricians

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Primary care provider at one of our 3 study sites (Boston Children's Hospital Adolescent/Young Adult Medicine, Martha Eliot Health Center, Children's Hospital Primary Care Center)

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Children's Hospital

Boston, Massachusetts, 02115, United States

Location

Related Publications (1)

  • Krakower DS, Naja-Riese GM, Edelstein ZR, Gandhi AD, Wahnich A, Fischer MA. Academic Detailing to Increase Prescribing of HIV Pre-exposure Prophylaxis. Am J Prev Med. 2021 Nov;61(5 Suppl 1):S87-S97. doi: 10.1016/j.amepre.2021.05.030.

    PMID: 34686295BACKGROUND

MeSH Terms

Conditions

Sexually Transmitted Diseases

Condition Hierarchy (Ancestors)

Communicable DiseasesInfectionsGenital DiseasesUrogenital DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 22, 2025

First Posted

February 3, 2025

Study Start (Estimated)

April 1, 2027

Primary Completion (Estimated)

March 30, 2030

Study Completion (Estimated)

March 30, 2030

Last Updated

January 26, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

IPD will not be shared due to participant privacy and data de-identification needs.

Locations